Sohrabi Bahram, Ghaffari Samad, Habibzadeh Afshin, Chaichi Parastoo, Kamalifar Amir
Dept. of Cardiology, Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Cardiol Res. 2013 Apr;4(2):68-73. doi: 10.4021/cr258w. Epub 2013 May 9.
Chronic total occlusions (CTO) comprises already one-third of percutaneous coronary interventions (PCIs). There is controversy in PCI results considering short-term and long-term outcomes. We aim to compare efficacy and outcome of successful versus unsuccessful PCI in CTO in 1 year follow-up.
In this retrospective study we choose 330 consecutive patients undergone PCI on a CTO of a native coronary artery (163 successful and 167 unsuccessful) in Madani Heart Hospital, Tabriz, Iran. Patients were followed for a mean period of about 15 ± 3 months. Major adverse cardiac events (MACE) in hospital and in follow-up were recorded comprising death, acute myocardial infarction, and need for repeat revascularization.
Patients with unsuccessful PCI compared to successful PCI were mainly male (87.4% vs. 77.3%; P < 0.02), had a higher incidence of diabetes mellitus (31.1% vs. 20.9%; P < 0.04) and hypertension (53.3% vs. 42.3%; P < 0.04). Most patients in successful group had single vessel disease (63.4% vs. 46.7%; P < 0.001) and less three-vessel disease (11.8% vs. 22.8%) compared to unsuccessful group. In-hospital MACE was insignificantly higher in unsuccessful PCI (17.4% vs. 11%). Unsuccessful PCI was significantly associated with higher rate of 12 months MACE (43.7% vs. 30.1%, P = 0.01), especially revascularization (41.3% vs. 25.2%, P = 0.02).
Although in hospital outcome was the same between groups, patients with successful PCI of CTO had a better one year follow-up outcome than unsuccessful PCI. However mortality rate was the same and main complications were due to revascularization.
慢性完全闭塞病变(CTO)已占经皮冠状动脉介入治疗(PCI)的三分之一。考虑到短期和长期结果,PCI结果存在争议。我们旨在比较CTO患者成功与不成功PCI在1年随访中的疗效和结局。
在这项回顾性研究中,我们选取了伊朗大不里士马丹尼心脏医院330例连续接受原发冠状动脉CTO的PCI患者(163例成功,167例不成功)。患者平均随访约15±3个月。记录住院期间和随访期间的主要不良心脏事件(MACE),包括死亡、急性心肌梗死和再次血管重建的需求。
与成功PCI患者相比,不成功PCI患者主要为男性(87.4%对77.3%;P<0.02),糖尿病发病率更高(31.1%对20.9%;P<0.04)和高血压发病率更高(53.3%对42.3%;P<0.04)。与不成功组相比,成功组大多数患者为单支血管病变(63.4%对46.7%;P<0.001),三支血管病变较少(11.8%对22.8%)。不成功PCI患者住院期间MACE略高(17.4%对11%)。不成功PCI与12个月MACE发生率较高显著相关(43.7%对30.1%,P=0.01),尤其是血管重建(41.3%对25.2%,P=0.02)。
虽然两组住院结局相同,但CTO成功PCI患者1年随访结局优于不成功PCI患者。然而,死亡率相同,主要并发症是由于血管重建。